w66最给利老牌

VOLUNTARY ANNOUNCEMENT - COMPLETION OF ISSUANCE OF FIRST TRANCHE OF PANDA BONDS

VOLUNTARY ANNOUNCEMENT - APPROVAL FOR MARKETING OF CATEGORY 1 INNOVATIVE DRUG ENVONALKIB CITRATE CAPSULES "ENVONALKIB (TQ-B3139)"

VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES BY CHIA TAI TIANQING UNDER THE SHARE INCENTIVE SCHEME

VOLUNTARY ANNOUNCEMENT - APPROVAL FOR MARKETING OF "GADOTERIDOL INJECTION"

VOLUNTARY ANNOUNCEMENT - KRAS G12C INHIBITOR "GARSORASIB TABLET (D-1553)" INCLUDED IN THE BREAKTHROUGH THERAPEUTIC DESIGNATION PROCESS

VOLUNTARY ANNOUNCEMENT - PUBLICATION OF STUDY FINDINGS OF PHASE II CLINICAL TRIAL OF KRAS G12C INHIBITOR "GARSORASIB TABLET (D-1553)" IN THE LANCET RESPIRATORY MEDICINE

VOLUNTARY ANNOUNCEMENT - PRESENTATION OF POSITIVE CLINICAL DATA FROM PHASE 1 STUDY OF FS222 (CD137/PD-L1) AT THE 2024 ASCO

RETIREMENT OF EXECUTIVE DIRECTOR